Financings Of The Fortnight: IPO Volume Up But Post-Offering Performance Falters

 
• By The Pink Sheet Daily

Some predict a washout for VC funds, too, but SV Life Sciences gathered a $523 million fund that will back 30-32 health care companies.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet